glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated The effect of inhibitors, agonists SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology GLP-1 receptor agonist versus DPP-4
Description
PMID: 7043459 PMCID: PMC345726
Molecular metabolism, 30, 72130
doi: 10.21037/atm.2017.03.107
And insulin resistance in obese individuals is primarily at the level of the muscle
Glucagon promotes satiety and increases energy expenditure in humans
